Somaiya Mayur Ian
SEC insider (Form 3/4/5 filer). CIK 0001760303. Chief Financial Officer at NewAmsterdam Pharma Co N.V. (NAMS). 17 reported Form 4/5 transactions since Sep 2024; latest on Jan 21, 2026. Located in NAARDEN, P7.
Companies Somaiya Mayur Ian has filed insider reports for
- NewAmsterdam Pharma Co N.V. (NAMS): Officer, Chief Financial Officer
Somaiya Mayur Ian
CIK: 0001760303
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NewAmsterdam Pharma Co N.V.
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Jan 21, 2026NAMS
NewAmsterdam Pharma Co N.V.
SaleDirect24.4K shares at avg. $33.80$823K - Jan 21, 2026NAMS
NewAmsterdam Pharma Co N.V.
ExerciseDirect39.8K shares at avg. $9.26$368K - Jan 21, 2026NAMS
NewAmsterdam Pharma Co N.V.
SaleDirect15.4K shares at avg. $33.25$513K - Jan 20, 2026NAMS
NewAmsterdam Pharma Co N.V.
SaleDirect19.6K shares at avg. $32.38$635K - Jan 20, 2026NAMS
NewAmsterdam Pharma Co N.V.
ExerciseDirect60.2K shares at avg. $9.26$558K - Jan 20, 2026NAMS
NewAmsterdam Pharma Co N.V.
SaleDirect900 shares at avg. $30.64$28K - Jan 20, 2026NAMS
NewAmsterdam Pharma Co N.V.
SaleDirect39.7K shares at avg. $31.78$1.3M - Jan 7, 2026NAMS
NewAmsterdam Pharma Co N.V.
AwardDirect25.5K shares- - Jan 5, 2026NAMS
NewAmsterdam Pharma Co N.V.
SaleDirect5.1K shares at avg. $33.25$170K - Jan 28, 2025NAMS
NewAmsterdam Pharma Co N.V.
SaleDirect3.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 21, 2026 | NAMS NewAmsterdam Pharma Co N.V. | Sale | 24,362 | $33.80 | $823,436 | Direct |
| Jan 21, 2026 | NAMS NewAmsterdam Pharma Co N.V. | Exercise | 39,784 | $9.26 | $368,400 | Direct |
| Jan 21, 2026 | NAMS NewAmsterdam Pharma Co N.V. | Sale | 15,422 | $33.25 | $512,782 | Direct |
| Jan 20, 2026 | NAMS NewAmsterdam Pharma Co N.V. | Sale | 19,604 | $32.38 | $634,778 | Direct |
| Jan 20, 2026 | NAMS NewAmsterdam Pharma Co N.V. | Exercise | 60,216 | $9.26 | $557,600 | Direct |
| Jan 20, 2026 | NAMS NewAmsterdam Pharma Co N.V. | Sale | 900 | $30.64 | $27,576 | Direct |
| Jan 20, 2026 | NAMS NewAmsterdam Pharma Co N.V. | Sale | 39,712 | $31.78 | $1,262,047 | Direct |
| Jan 7, 2026 | NAMS NewAmsterdam Pharma Co N.V. | Award | 25,500 | - | $0 | Direct |
| Jan 5, 2026 | NAMS NewAmsterdam Pharma Co N.V. | Sale | 5,118 | $33.25 | $170,174 | Direct |
| Jan 28, 2025 | NAMS NewAmsterdam Pharma Co N.V. | Sale | 3,405 | - | $0 | Direct |
1-10 of 17 transactions